Definition/General

Introduction:
-Cervical endometriosis is the presence of ectopic endometrial tissue (glands and stroma) within the cervical wall
-It represents implantation of functional endometrial tissue outside its normal location in the uterine cavity.
Origin:
-Results from retrograde menstruation, lymphatic or hematogenous spread, or direct implantation of endometrial tissue
-May also arise from metaplastic transformation of cervical tissues.
Classification:
-WHO Classification categorizes as benign ectopic endometrial tissue
-Part of endometriosis spectrum involving extra-uterine locations
-May be superficial or deep cervical involvement.
Epidemiology:
-Affects 5-15% of reproductive-age women with endometriosis
-Peak incidence 25-35 years
-Associated with pelvic endometriosis in majority of cases
-Often underdiagnosed.

Clinical Features

Presentation:
-Cyclic pelvic pain corresponding to menstrual periods
-Abnormal vaginal bleeding
-Dyspareunia
-Blue or purple nodular lesions on cervical examination.
Symptoms:
-Cyclical pelvic pain (most common)
-Dysmenorrhea
-Post-coital bleeding
-Intermenstrual bleeding
-Dyspareunia
-Lower back pain during menstruation.
Risk Factors:
-Reproductive age
-Family history of endometriosis
-Nulliparity
-Early menarche
-Short menstrual cycles
-Retrograde menstruation
-Previous cervical procedures.
Screening:
-Pelvic examination may reveal blue-black nodules
-Transvaginal ultrasound
-MRI for deep endometriosis
-Laparoscopy for definitive diagnosis.

Master Cervical Endometriosis Pathology with RxDx

Access 100+ pathology videos and expert guidance with the RxDx app

Gross Description

Appearance:
-Blue, purple, or dark red nodular lesions on cervical surface
-Cystic areas containing old blood ("chocolate cysts")
-Firm, indurated areas.
Characteristics:
-Size variable (few mm to several cm)
-Blue-black to red-brown coloration
-Firm to cystic consistency
-May have surface ulceration.
Size Location:
-Usually located on posterior cervical lip
-May involve anterior cervix or lateral aspects
-Can extend into cervical stroma
-Single or multiple foci.
Multifocality:
-Often multifocal lesions
-May be associated with vaginal or uterine endometriosis
-Can involve multiple pelvic organs.

Microscopic Description

Histological Features:
-Ectopic endometrial glands and stroma within cervical tissue
-Glands lined by endometrial-type epithelium
-Surrounding endometrial stroma with evidence of cyclic hormonal changes.
Cellular Characteristics:
-Endometrial glands: columnar epithelium with basally located nuclei
-Endometrial stroma: spindle-shaped cells with oval nuclei
-Hemosiderin-laden macrophages.
Architectural Patterns:
-Irregular endometrial glands surrounded by endometrial stroma
-Cystic dilatation of glands common
-Hemorrhage and hemosiderin deposition.
Grading Criteria:
-Benign condition (no grading system)
-Severity assessed by extent of involvement and degree of fibrosis and adhesions.

Immunohistochemistry

Positive Markers:
-CD10 positive in endometrial stroma
-Estrogen receptor (ER) positive
-Progesterone receptor (PR) positive
-CK7 positive in glandular epithelium.
Negative Markers:
-p16 typically negative
-CEA usually negative
-TTF-1 negative
-PAX8 may be positive but not specific.
Diagnostic Utility:
-CD10 is most useful marker for endometrial stroma identification
-Hormone receptors confirm endometrial nature
-CK7 highlights glandular component.
Molecular Subtypes:
-No specific molecular subtypes
-Hormone-responsive tissue similar to eutopic endometrium.

Molecular/Genetic

Genetic Mutations:
-Similar genetic alterations to eutopic endometrium
-PTEN mutations reported
-ARID1A mutations in some cases
-KRAS mutations occasionally present.
Molecular Markers:
-Hormone receptors (ER, PR) expressed
-CD10 positive stroma
-Normal p53 expression
-Variable Ki-67 depending on cycle phase.
Prognostic Significance:
-Benign condition with excellent prognosis
-May cause fertility issues
-Risk of malignant transformation extremely low (<1%).
Therapeutic Targets:
-Hormonal suppression (GnRH agonists, progestins)
-Surgical excision
-Anti-inflammatory therapy
-Pain management strategies.

Differential Diagnosis

Similar Entities:
-Adenomyosis
-Cervical adenocarcinoma
-Mesonephric remnants
-Endocervical glands
-Metastatic endometrial adenocarcinoma.
Distinguishing Features:
-Endometriosis: CD10+ stroma, hormone receptors+
-Adenocarcinoma: malignant features, invasion
-Mesonephric: CD10-, hormone receptors-.
Diagnostic Challenges:
-Small biopsies may lack stromal component
-Distinction from reactive endocervical glands
-Differentiation from adenocarcinoma.
Rare Variants:
-Polypoid endometriosis
-Endometriosis with smooth muscle metaplasia
-Endometriosis with malignant transformation.

Sample Pathology Report

Template Format

Sample Pathology Report

Complete Report: This is an example of how the final pathology report should be structured for this condition.

Specimen Information

[specimen type], measuring [size] cm in greatest dimension

Diagnosis

[diagnosis name]

Classification

Classification: [classification system] [grade/type]

Histological Features

Shows [architectural pattern] with [nuclear features] and [mitotic activity]

Size and Extent

Size: [X] cm, extent: [local/regional/metastatic]

Margins

Margins are [involved/uninvolved] with closest margin [X] mm

Lymphovascular Invasion

Lymphovascular invasion: [present/absent]

Lymph Node Status

Lymph nodes: [X] positive out of [X] examined

Special Studies

IHC: [marker]: [result]

Molecular: [test]: [result]

[other study]: [result]

Prognostic Factors

Prognostic factors: [list factors]

Final Diagnosis

Final diagnosis: [complete diagnosis]